{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:30:45Z","timestamp":1783474245611,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T00:00:00Z","timestamp":1302739200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1741-7015-9-38","type":"journal-article","created":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T14:36:11Z","timestamp":1302791771000},"source":"Crossref","is-referenced-by-count":67,"title":["Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis"],"prefix":"10.1186","volume":"9","author":[{"given":"Angel","family":"Lanas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Garcia-Tell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Armada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Oteo-Alvaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,14]]},"reference":[{"key":"393_CR1","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/ard.59.12.936","volume":"9","author":"A Pendleton","year":"2000","unstructured":"Pendleton A, Arden N, Dougados M, Doherty M, Bannwarth B, Bijlsma JW, Cluzeau F, Cooper C, Dieppe PA, G\u00fcnther KP, Hauselmann HJ, Herrero-Beaumont G, Kaklamanis PM, Leeb B, Lequesne M, Lohmander S, Mazieres B, Mola EM, Pavelka K, Serni U, Swoboda B, Verbruggen AA, Weseloh G, Zimmermann-Gorska : EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2000, 9: 936-944. 10.1136\/ard.59.12.936.","journal-title":"Ann Rheum Dis"},{"key":"393_CR2","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/S0885-3924(02)00372-X","volume":"23","author":"TJ Schnitzer","year":"2002","unstructured":"Schnitzer TJ: Update of ACR guidelines for osteoarthritis: role of the coxibs. J Pain Symptom Manage. 2002, 23: S24-30. 10.1016\/S0885-3924(02)00372-X. discussion: S31-34","journal-title":"J Pain Symptom Manage"},{"key":"393_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11938-006-0033-4","volume":"9","author":"A Lanas","year":"2006","unstructured":"Lanas A: Prevention and treatment of NSAID-induced gastroduodenal injury. Curr Treat Options Gastroenterol. 2006, 9: 147-156. 10.1007\/s11938-006-0033-4.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"393_CR4","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cgh.2007.03.011","volume":"5","author":"A Rostom","year":"2007","unstructured":"Rostom A, Muir K, Dub\u00e9 C, Jolicoeur E, Boucher M, Joyce J, Tugwell P, Wells GW: Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review. Clin Gastroenterol Hepatol. 2007, 5: 818-828. 10.1016\/j.cgh.2007.03.011.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"393_CR5","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","volume":"332","author":"PM Kearney","year":"2006","unstructured":"Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C: Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-infl ammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006, 332: 1302-1308. 10.1136\/bmj.332.7553.1302.","journal-title":"BMJ"},{"key":"393_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1741-7015-3-17","volume":"3","author":"LA Garc\u00eda Rodr\u00edguez","year":"2005","unstructured":"Garc\u00eda Rodr\u00edguez LA, Gonz\u00e1lez-P\u00e9rez A: Long-term use of non-steroidal antiinflammatory drugs and the risk of myocardial infarction in the general population. BMC Med. 2005, 3: 17-10.1186\/1741-7015-3-17.","journal-title":"BMC Med"},{"key":"393_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1742-7843.2006.pto_302.x","volume":"98","author":"S Hern\u00e1ndez-D\u00edaz","year":"2006","unstructured":"Hern\u00e1ndez-D\u00edaz S, Varas-Lorenzo C, Garc\u00eda Rodr\u00edguez LA: Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction. Basic Clin Pharmacol Toxicol. 2006, 98: 266-274. 10.1111\/j.1742-7843.2006.pto_302.x.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"393_CR8","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1001\/jama.296.13.jrv60011","volume":"296","author":"P McGettigan","year":"2006","unstructured":"McGettigan P, Henry D: Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA. 2006, 296: 1633-1644. 10.1001\/jama.296.13.jrv60011.","journal-title":"JAMA"},{"key":"393_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1517\/14740330903311023","volume":"8","author":"S Harirforoosh","year":"2009","unstructured":"Harirforoosh S, Jamali F: Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf. 2009, 8: 669-681. 10.1517\/14740330903311023.","journal-title":"Expert Opin Drug Saf"},{"key":"393_CR10","unstructured":"FDA. Safety Alerts for Human Medical Products. COX-2 Selective and Non-Selective Non-Steroidal Anti-Infl ammatory Drugs NSAIDs. 2005, [ http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm150314.htm ]"},{"key":"393_CR11","unstructured":"EMEA. EMEA Press Release: European Medicines Agency Review Concludes Positive Benefi t-risk Balance for Non-selective NSAIDs. CHMP 24 October 2006. Doc. Ref. EMEA\/413136\/2006, [ http:\/\/www.emea.europa.eu\/pdfs\/human\/press\/pr\/41313606.pdf ]"},{"key":"393_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/ard.2004.028886","volume":"64","author":"W Zhang","year":"2005","unstructured":"Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, Hauselmann HJ, Herrero-Beaumont G, Jordan K, Kaklamanis P, Leeb B, Lequesne M, Lohmander S, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Swoboda B, Varatojo R, Verbruggen G, Zimmermann-Gorska I, Dougados M, EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT): EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2005, 64: 669-681. 10.1136\/ard.2004.028886.","journal-title":"Ann Rheum Dis"},{"key":"393_CR13","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","volume":"43","author":"American College of Rheumatology Subcommittee on Osteoarthritis Guidelines","year":"2000","unstructured":"American College of Rheumatology Subcommittee on Osteoarthritis Guidelines: Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum. 2000, 43: 1905-1915. 10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P.","journal-title":"Arthritis Rheum"},{"key":"393_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1699-258X(09)70197-4","volume":"5","author":"G Bori","year":"2009","unstructured":"Bori G, Hern\u00e1ndez B, Gobbo M, Lanas A, Salazar M, Ter\u00e1n L, Jos\u00e9 Federico D\u00edaz-Gonz\u00e1lez JF, Espinosa R, Galv\u00e1n F, Garc\u00eda Rodr\u00edguez LA, \u00c1lvaro-Gracia A, \u00c1vila H, Carmona L, Rivera J, Ventura L: Uso apropiado de los antiinflamatorios no esteroideos en reumatolog\u00eda: documento de consenso de la Sociedad Espa\u00f1ola de Reumatolog\u00eda y el Colegio Mexicano de Reumatolog\u00eda. Reumatol Clin. 2009, 5: 3-12. 10.1016\/S1699-258X(09)70197-4.","journal-title":"Reumatol Clin"},{"key":"393_CR15","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1111\/j.1572-0241.2008.02200.x","volume":"103","author":"FKL Chan","year":"2008","unstructured":"Chan FKL, Abraham NS, Scheiman JM, Laine L: Management of patients on nonsteroidal anti-inflammatory drugs: A clinical practice recommendation from the First International Working Party on gastrointestinal and cardiovascular effects of nonsteroidal anti-inflammatory drugs and anti-platelet agents. Am J Gastroenterol. 2008, 103: 2908-2918. 10.1111\/j.1572-0241.2008.02200.x.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"393_CR16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1136\/ard.2010.128660","volume":"70","author":"G Burmester","year":"2011","unstructured":"Burmester G, Lanas A, Biasucci L, Hermann M, Lohmander S, Olivieri I, Scarpignato C, Smolen J, Stoevelaar H, on behalf of the European Expert Panel on the Appropriate Use of NSAID: The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Ann Rheum Dis. 2011, 70 (5): 818-822. 10.1136\/ard.2010.128660.","journal-title":"Ann Rheum Dis"},{"key":"393_CR17","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1136\/ard.2009.123166","volume":"69","author":"A Lanas","year":"2010","unstructured":"Lanas A, Tornero J, Zamorano JL: Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study. Ann Rheum Dis. 2010, 69: 1453-1458. 10.1136\/ard.2009.123166.","journal-title":"Ann Rheum Dis"},{"key":"393_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/07853890600925843","volume":"38","author":"A Lanas","year":"2006","unstructured":"Lanas A, Hunt R: Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies. Ann Med. 2006, 38: 415-428. 10.1080\/07853890600925843.","journal-title":"Ann Med"},{"key":"393_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1741-7015-4-22","volume":"4","author":"S Hern\u00e1ndez-D\u00edaz","year":"2006","unstructured":"Hern\u00e1ndez-D\u00edaz S, Garc\u00eda Rodr\u00edguez LA: Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications. BMC Med. 2006, 4: 22-10.1186\/1741-7015-4-22.","journal-title":"BMC Med"},{"key":"393_CR20","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1365-2036.2004.01935.x","volume":"19","author":"FKL Chan","year":"2004","unstructured":"Chan FKL, Graham Y: Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications - review and recommendations based on risk assessment. Aliment Pharmacol Ther. 2004, 19: 1051-1061. 10.1111\/j.1365-2036.2004.01935.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"393_CR21","doi-asserted-by":"publisher","first-page":"c7086","DOI":"10.1136\/bmj.c7086","volume":"342","author":"S Trelle","year":"2011","unstructured":"Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, J\u00fcni P: Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011, 342: c7086-10.1136\/bmj.c7086.","journal-title":"BMJ"},{"key":"393_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/ard.2006.068015","volume":"67","author":"KS Steen","year":"2008","unstructured":"Steen KS, Nurmohamed MT, Visman I, Heijerman M, Boers M, Dijkmans BA, Lems WF: Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritis. Ann Rheum Dis. 2008, 67: 256-259. 10.1136\/ard.2006.068015.","journal-title":"Ann Rheum Dis"},{"key":"393_CR23","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/j.1365-2036.2010.04281.x","volume":"31","author":"VE Valkhoff","year":"2010","unstructured":"Valkhoff VE, van Soest EM, Sturkenboom MC, Kuipers EJ: Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs). Aliment Pharmacol Ther. 2010, 31: 1218-1228. 10.1111\/j.1365-2036.2010.04281.x.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-9-38.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1741-7015-9-38\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-9-38","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T12:47:30Z","timestamp":1468846050000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/1741-7015-9-38"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,14]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["393"],"URL":"https:\/\/doi.org\/10.1186\/1741-7015-9-38","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,14]]},"article-number":"38"}}